Pelin Candarlioglu
Company: GlaxoSmithKline
Job title: Cell Biologist & Complex In Vitro Models Bioengineer
Seminars:
Chair’s Closing Remarks 6:00 pm
day: Day Two
Developing Tumour-on-Chip Models for Evaluating Adoptive Cell Therapy Efficacy 11:50 am
Exploring the efficacy of CAR-Ts in complex in vitro translational models Leveraging new insights from in vitro studies to further clinical confidence Effectively translating the efficacy of CAR therapies for patientsRead more
day: Day Two
Chair’s Opening Remarks 8:50 am
day: Day Two